|
|
|
|
|
非在研适应症- |
最高研发阶段临床1/2期 |
首次获批国家/地区- |
首次获批日期- |
A Randomized, Double-Blind, Placebo-Controlled Trial Using Cannabidiol and Palmitoylethanolamide for the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet
The purpose of the study is to evaluate whether the DIA/NPR-6 is a better pain reliever in patients with diabetic neuropathic pain of the feet compared to placebo.
100 项与 Pure Green Pharmaceuticals, Inc. 相关的临床结果
0 项与 Pure Green Pharmaceuticals, Inc. 相关的专利(医药)
100 项与 Pure Green Pharmaceuticals, Inc. 相关的药物交易
100 项与 Pure Green Pharmaceuticals, Inc. 相关的转化医学